331 related articles for article (PubMed ID: 32239716)
1. Matrix stiffness controls cardiac fibroblast activation through regulating YAP via AT
Niu L; Jia Y; Wu M; Liu H; Feng Y; Hu Y; Zhang X; Gao D; Xu F; Huang G
J Cell Physiol; 2020 Nov; 235(11):8345-8357. PubMed ID: 32239716
[TBL] [Abstract][Full Text] [Related]
2. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation.
Adapala RK; Kanugula AK; Paruchuri S; Chilian WM; Thodeti CK
Basic Res Cardiol; 2020 Jan; 115(2):14. PubMed ID: 31925567
[TBL] [Abstract][Full Text] [Related]
3. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
4. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis.
Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G
Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606
[TBL] [Abstract][Full Text] [Related]
5. Pathological matrix stiffness promotes cardiac fibroblast differentiation through the POU2F1 signaling pathway.
Li M; Wu J; Hu G; Song Y; Shen J; Xin J; Li Z; Liu W; Dong E; Xu M; Zhang Y; Xiao H
Sci China Life Sci; 2021 Feb; 64(2):242-254. PubMed ID: 32617828
[TBL] [Abstract][Full Text] [Related]
6. Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
Perestrelo AR; Silva AC; Oliver-De La Cruz J; Martino F; Horváth V; Caluori G; Polanský O; Vinarský V; Azzato G; de Marco G; Žampachová V; Skládal P; Pagliari S; Rainer A; Pinto-do-Ó P; Caravella A; Koci K; Nascimento DS; Forte G
Circ Res; 2021 Jan; 128(1):24-38. PubMed ID: 33106094
[TBL] [Abstract][Full Text] [Related]
7. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix type modulates mechanotransduction of stem cells.
Stanton AE; Tong X; Yang F
Acta Biomater; 2019 Sep; 96():310-320. PubMed ID: 31255664
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
[TBL] [Abstract][Full Text] [Related]
10. Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases.
Tian G; Ren T
Eur J Cell Biol; 2023 Jun; 102(2):151288. PubMed ID: 36696810
[TBL] [Abstract][Full Text] [Related]
11. Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis.
Li S; Li C; Zhang Y; He X; Chen X; Zeng X; Liu F; Chen Y; Chen J
Theranostics; 2019; 9(17):4993-5008. PubMed ID: 31410197
[TBL] [Abstract][Full Text] [Related]
12. M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis After Reperfusion Injury.
Yue Y; Huang S; Wang L; Wu Z; Liang M; Li H; Lv L; Li W; Wu Z
Circ J; 2020 Mar; 84(4):626-635. PubMed ID: 32161201
[TBL] [Abstract][Full Text] [Related]
13. Substrate stiffness modulates cardiac fibroblast activation, senescence, and proinflammatory secretory phenotype.
Felisbino MB; Rubino M; Travers JG; Schuetze KB; Lemieux ME; Anseth KS; Aguado BA; McKinsey TA
Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H61-H73. PubMed ID: 37889253
[TBL] [Abstract][Full Text] [Related]
14. Keloid fibroblasts have elevated and dysfunctional mechanotransduction signaling that is independent of TGF-β.
Deng Z; Subilia M; Chin IL; Hortin N; Stevenson AW; Wood FM; Prêle CM; Choi YS; Fear MW
J Dermatol Sci; 2021 Oct; 104(1):11-20. PubMed ID: 34538705
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix stiffness controls cardiac fibroblast proliferation via the nuclear factor-Y (NF-Y) transcription factor.
Ebrahimighaei R; Tarassova N; Bond SC; McNeill MC; Hathway T; Vohra H; Newby AC; Bond M
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119640. PubMed ID: 37996060
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction.
Zhang L; Yin H; Jiao L; Liu T; Gao Y; Shao Y; Zhang Y; Shan H; Zhang Y; Yang B
Cell Physiol Biochem; 2018; 45(4):1641-1653. PubMed ID: 29486470
[TBL] [Abstract][Full Text] [Related]
17. Targeting JMJD3 histone demethylase mediates cardiac fibrosis and cardiac function following myocardial infarction.
Long F; Wang Q; Yang D; Zhu M; Wang J; Zhu Y; Liu X
Biochem Biophys Res Commun; 2020 Aug; 528(4):671-677. PubMed ID: 32513540
[TBL] [Abstract][Full Text] [Related]
18. Cardiac fibrosis.
Frangogiannis NG
Cardiovasc Res; 2021 May; 117(6):1450-1488. PubMed ID: 33135058
[TBL] [Abstract][Full Text] [Related]
19. sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling.
Lin H; Angeli M; Chung KJ; Ejimadu C; Rosa AR; Lee T
Am J Physiol Cell Physiol; 2016 Nov; 311(5):C710-C719. PubMed ID: 27605451
[TBL] [Abstract][Full Text] [Related]
20. Fibroblasts and the extracellular matrix in right ventricular disease.
Frangogiannis NG
Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
